* Please don't just dump a link with no comment.
* Snippets are SHORT amounts of text that should be followed by a source link.
* contact notmsnmoney@live.com if you need help with something.
Ebola Risks May Make Airlines And Hotel Chains A Short-Term Short Oct. 2, 2014 4:24 AM ET Includes: AAL, H, IHG, MAR, UAL
Disclosure: The author has no positions in any stocks mentioned, but may initiate a short position in H, MAR, IHG, AAL over the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.
Summary Ebola outbreaks have historically been quite limited. The current outbreak is much larger and more widespread than any since at least 1994. There is now one case in the United States.
If the spread continues, the effect on the travel and hospitality industry could be severe. Ebola is not new. There have been outbreaks every few years or so in Africa. But the current outbreak is larger and growing more quickly than any before. Equally importantly, the infections are more widespread and now include Liberia, Nigeria, Sierra Leone, Guinea and Senegal in addition to one in the United States.
Three Dallas paramedics and several emergency room workers at Texas Health Presbyterian Hospital are off work and under observation after making contact with the patient being treated for Ebola. (USA Today)
The Ebola outbreak in West Africa is threatening Exxon Mobil’s (XOM) activities in the region, including plans to drill for oil there.
Exxon CEO Rex Tillerson said during a news conference reported by Reuters the company is having second thoughts about plans to start offshore drilling in some areas in West Africa due to concerns. The company has also banning business travel by employees to areas of the world affected by the disease.
Shares of Exxon are down 7 cents, or 0.08%, to $92.80. Africa is home to 20% of Exxon’s crude oil developed proved reserves and 3% of natural gas. Meanwhile, 20% of Exxon’s undeveloped proved oil reserves are in Africa.
There are not many large U.S. companies with significant activity in the sub-Saharan Africa region. There are just seven companies in the Standard & Poor’s 500 that have disclosed an undefined but notable geographic locations in the region, says S&P Capital IQ including:
Company Ticker Accenture ACN American Int’l AIG Chevron CVX Cisco Systems CSCO Citigroup C Morgan Stanley MS Starwood Hotels HOT
You said, "Just a quick thought. Why are people believing the authorities in Africa on the severity of the situation?"
Seeing is believing if I understood your question. I know I would get the message if I saw people being abandoned and dying in the streets ...
U.S. Troops Arrive to Combat Deadly Ebola Outbreak - U.S. troops are arriving in Monrovia, Liberia as part of a plan to build tent hospitals and train local nurses to treat anEbola epidemic that is showing signs of gaining speed. Video by WSJ's Drew Hinshaw.
Seeing is believing is part of it for sure. I guess, I was meaning it more like how many of these people fleeing are also infected? How many are spreading out further into other parts if Africa? We already know that tons of cases are going unreported...
Democracy is the worst form of government except for all those others that have been tried. -Winston Churchill, House of Commons 11th of November, 1947.
“The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will be readily taken up… His duty is to lay the foundation for those who are to come, and point the way.” – Nikola Tesla
Jerusalem — September 29, 2014 … By Israel News Agency Staff
Jerusalem — September 29, 2014 … Israeli security sources say that the deadly Ebola virus may be spreading among member of ISIS (Islamic State) in Syria. The report states that dozens of ISIS terrorists have come down with symptoms identical to the killer virus which has claimed over 6,574 victims in five West African countries – Senegal and Nigeria are the other two – with 3,091 deaths reported.
I know eh? Also, it goes to show you just how massive this outbreak is. One, just ONE person is infected and they are following 100! Quarantining 4 under armed guard... There is no way that we are getting accurate numbers out of Africa. I guess we'll see where it leads..
Democracy is the worst form of government except for all those others that have been tried. -Winston Churchill, House of Commons 11th of November, 1947.
“The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will be readily taken up… His duty is to lay the foundation for those who are to come, and point the way.” – Nikola Tesla
Jerusalem — September 29, 2014 … By Israel News Agency Staff
Jerusalem — September 29, 2014 … Israeli security sources say that the deadly Ebola virus may be spreading among member of ISIS (Islamic State) in Syria. The report states that dozens of ISIS terrorists have come down with symptoms identical to the killer virus which has claimed over 6,574 victims in five West African countries – Senegal and Nigeria are the other two – with 3,091 deaths reported.
But, but, but they have the outbreak under control in Nigeria - haven't you heard? Never mind that Boko Haram controls a chunk of land the size of Ireland - which would make it impossible to know if the outbreak was stopped in the whole country. Never mind that Nigeria has one of the lowest populations online in the world - which means information travels at the spee of snail there. Never mind that Africa is a known I.S. training ground and they are transporting ebola all over the region, it's all a "non-issue".
Democracy is the worst form of government except for all those others that have been tried. -Winston Churchill, House of Commons 11th of November, 1947.
“The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will be readily taken up… His duty is to lay the foundation for those who are to come, and point the way.” – Nikola Tesla
Post by damnotagain on Oct 3, 2014 20:56:30 GMT -5
Nice letter To the president .
just a few questions ? how important is the development of monoclonal antibiotics to the treatment of ebola? Does it have to target all 5 versions of the virus or just the EHF version?
I wondered when someone was going to "throw EBOLA" over the I.S. fence!
Exactly, b! It's in their backyard. What is a big form of travel in this part of the world? Camels. What has been spreading MERS? Camels. Where do viruses mutate? Animals. MERS=respiratory disease. Biggest concern for Ebola=mutates into respiratory virus..
Democracy is the worst form of government except for all those others that have been tried. -Winston Churchill, House of Commons 11th of November, 1947.
“The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will be readily taken up… His duty is to lay the foundation for those who are to come, and point the way.” – Nikola Tesla
just a few questions ? how important is the development of monoclonal antibiotics to the treatment of ebola? Does it have to target all 5 versions of the virus or just the EHF version?
thank you!
Here are a few links that might be helpful until I can address your question....
Ebola Patient in Dallas Struggling to Survive, Says CDC Head
By Reuters
Filed: 10/5/14 at 5:33 PM
A general view of the Texas Health Presbyterian Hospital is seen in Dallas, Texas, October 4, 2014. U.S. health officials have fielded inquiries about as many as 100 potential cases of Ebola since the first patient with the deadly virus was detected in the country. Jim Young/Reuters • Filed Under: U.S. The first person diagnosed with Ebola in the United States was fighting for his life at a Dallas hospital on Sunday and appeared not to be receiving any of the experimental medicines for the virus, the director of the U.S. Centers for Disease Control and Prevention said.
Thomas Eric Duncan became ill after arriving in the Texas city from Liberia two weeks ago, heightening concerns that the worst Ebola epidemic on record could spread from West Africa, where it began in March. The hemorrhagic fever has killed at least 3,400 people out of at least 7,490 probable, suspected and confirmed cases.
"The man in Dallas, who is fighting for his life, is the only patient to develop Ebola in the United States," Dr.Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention (CDC), said on CNN's "State of the Union."
Newsweek Magazine is Back In Print In a media briefing with reporters on Sunday, Frieden said he was scheduled to brief President Barack Obama on Monday.
Frieden said doses of the experimental medicine ZMapp were "all gone" and that the drug, produced bySan Diego-based Mapp Biopharmaceutical, is "not going to be available anytime soon."
Asked about a second experimental drug, made by Canada's Tekmira Pharmaceuticals Corp, he said it "can be quite difficult for patients to take." Frieden said the doctor and the patient's family would decide whether to use the drug, but if "they wanted to, they would have access to it."
"As far as we understand, experimental medicine is not being used," Frieden said. "It’s really up to his treating physicians, himself, his family what treatment to take." Duncan remained in critical condition, Wendell Watson, spokesman for Texas Health Presbyterian Hospital in Dallas, said on Sunday.
Texas law enforcement officials were also seeking a "low- risk" homeless man who was one of 38 people who had potentially had contact with Duncan, health officials told the media briefing. The man had tested negative for fever on Saturday, but officials said they wanted to continue to monitor him.
"We believe that we need to work to locate him to make sure he is continued to be monitored compassionately," David Lakey, commissioner of Texas Department of State Health Services, told the media briefing.
At Wilshire Baptist Church in Dallas, parishioners prayed for Duncan, congregation member Louise Troh - who is quarantined because of her close contact with Duncan - and both of their families.
"Although this disease has become personal to us, we realize we're not the first to know its devastation, and we are not the ones most desperately affected," Associate Pastor Mark Wingfeld told the church audience.
He encouraged parishioners to focus not only on the Dallas family but also on those in West Africa stricken with Ebola.
In Nebraska, another hospital was preparing for the arrival of an Ebola patient who contracted the virus inLiberia, a spokesman said on Sunday.
Nebraska Medical Center spokesman Taylor Wilson would only identify the patient as a male U.S. citizen expected to arrive on Monday. But the father of Ashoka Mukpo, a freelance cameraman working for NBC News who contracted Ebola in Liberia, told Reuters on Friday that his son was going to Nebraska for treatment.
The Nebraska hospital last month also treated and released, Dr. Rick Sacra, an American missionary who also contracted Ebola in Liberia.
Sacra was admitted to a Massachusetts hospital on Saturday for a likely respiratory infection that is not believed to be a recurrence of the disease, hospital officials there said. Duncan's case has highlighted problems that American public health officials are trying furiously to address: The Dallas hospital that admitted him initially did not recognize the deadly disease and sent him home with antibiotics, only for him to return two days later in an ambulance.
"The issue of the missed diagnosis initially is concerning," Frieden said, adding that public health officials had redoubled their efforts to raise awareness of the disease. "We're seeing more people calling us, considering the possibility of Ebola - that's what we want to see," he said on CNN. "We don't want people not to be diagnosed."
Frieden said he was confident the disease would not spread widely within the United States. U.S. officials are also scaling up their response in West Africa, where Ebola presents an enormous challenge, he added.
"But it's going to take time," Frieden said. "The virus is spreading so fast that it's hard to keep up."
When asked on Sunday if the United States should suspend flights to and from affected countries or impose a visa ban on travelers from those countries, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said "absolutely not."
"When you start closing off countries like that, there is a real danger of making things worse," Fauci said on "Fox News Sunday."
"You can cause unrest in the country," he said. "It’s conceivable that governments could fall if you just isolate them completely."
The CDC has identified 10 people who had direct contact with Duncan as being at greatest risk of infection. Another 38 were being monitored as potential contacts, out of 114 people initially evaluated for exposure risks. None from either group has shown symptoms, health officials said.
Ebola, which can cause fever, vomiting and diarrhea, spreads through contact with bodily fluids such as blood or saliva.
Quit when you’ll be mediocre, when the returns aren’t worth the investment, when you no longer think you’ll enjoy the ends. Stick when the dip is the obstacle that creates scarcity, when you’re simply bridging the gap between beginner’s luck and mastery.The Dip, Seth Godin
In all circumstances "Be strong and courageous" (Josh.1:9)
Every day stand guard at the door of your mind, and you alone will decide on what thoughts and beliefs you let into your life. Tony Robbins
Sierra Leone records 121 Ebola deaths in a single day
Mon Oct 6, 2014 6:45am
FREETOWN (Reuters) - Sierra Leone recorded 121 deaths from Ebola and scores of new infections in one of the single deadliest days since the disease appeared in the West African country more than four months ago, government health statistics showed on Sunday.
The figures, which covered the period through Saturday, put the total number of deaths at 678, up from 557 the day before. The daily statistics compiled by Sierra Leone's Emergency Operations Centre also showed 81 new cases of the hemorrhagic fever.
Ebola was first reported in Guinea in March and has since spread to neighbouring Liberia and Sierra Leone in what has become the worst epidemic of the disease since Ebola was identified in 1976. CONTINUED: af.reuters.com/article/topNews/idAFKCN0HV0EW20141006
Texas Ebola patient fighting for life, new US drug ‘all gone’
October 06, 2014
The first patient to be diagnosed with Ebola in the US is in critical condition at a Dallas hospital and is not receiving any of the new experimental drugs for the virus, which has killed over 3,400 people in Africa, media reports say.
Thomas Eric Duncan contracted the disease in Liberia and began to show symptoms after arriving in Texas two weeks ago, causing a panic that he could have infected another 10 individuals.
READ MORE: Dallas damage control: Ebola-positive man possibly infected 10 in Texas
Dr. Thomas Frieden, director of the US Centers for Disease Control and Prevention (CDC), said Duncan is in critical condition, adding that the patient is not receiving ZMapp – an experimental medicine – because it is “all gone” and is “not going to be available anytime soon.”
The comments were made during a briefing with reporters on Sunday.
Speaking on another experiential drug produced by Canada’s Tekmira Pharmaceuticals Corp, Frieden described the treatment as “difficult for patients to take.”
The decision whether to give this drug to the patient will be made by his doctor and family members, but “access” to the medicine will be made available.
“As far as we understand, experimental medicine is not being used,” Frieden said. “It’s really up to his treating physicians, himself, his family what treatment to take.”
LOS ANGELES (MarketWatch) — The number of companies with a hand in trying to find an effective combatant against the deadly Ebola virus is growing almost as quickly as the disease spreads, with one player receiving critical regulatory approval on Monday.
The U.S. Food and Drug Administration has authorized a drug developed by Chimerix Inc. CMRX, +7.52% for use as an emergency investigational new treatment in the rapid deployment against Ebola. Chimerix officials said in a press release the application was granted for the drug known as brincidofovir in light of requests made by physicians treating the illness.
“Based on in vitro data from work conducted by the [Centers for Disease Control] and the National Institutes of Health suggesting brincidofovir’s activity against Ebola, we are hopeful that brincidofovir may offer a potential treatment for [the] Ebola virus disease during this outbreak,” Chimerix Chief Executive Dr. M. Michelle Berry said in a prepared statement.
Shares of Chimerix were up nearly 5% to $31.50 in recent action.
Meanwhile, it seemed as if the first line of defenders against Ebola that gained a lot of attention last week started to give way to Chimerix and other stock when the market opened on Monday.
The most prominent decliner was Tekmira Pharmaceuticals TKMR, -17.51% , which lost the ground it gained last week after Leerink Research cut its rating on the company’s stock to “market perform” from “outperform.” Leerink analyst Michael Schmidt said the runup in the company’s valuation was too high, based on how far its Ebola therapy has gotten in the regulatory approval process and how much it would add to Tekmira’s bottom line.
Schmidt noted that the company’s $340 million valuation increase would assume a 90% probability of success for approval from the FDA, an order for a stockpile worth $500 million and a contract that would be renewed every three years with 30% net margin.
“Our prior base case assumption had been a $225 million stockpile contract following FDA approval of [Tekmira’s drug], as indicated by the [Defense Department] prior to the diagnosis of the Ebola patient in Dallas,” Schmidt’s note said.
Shares of Tekmira were off 16% in recent action to $24.80.
Other stocks highlighted in a MarketWatch story last week also started to fall, including BioCryst Pharmaceuticals Inc. BCRX, -7.38% , off more than 12% in recent action to $11.21, NewLink Genetics Corp. NLNK, -7.85% , down more than 6% to $22.05, and Sarepta Therapeutics Inc. SRPT, -5.47% which lost 5% to $22.07.
Some stocks that weren’t highlighted started to gain ground, including Novavax Inc. NVAX, +2.68% , up more than 2% to $4.20 and Inovio Pharmaceuticals Inc. INO, +3.35% , which was up substantially at first but only marginally in recent action to $11.05.
A smaller player, NanoViricides Inc. NNVC, -4.08% ,was off slightly in recent action. The company last week said it was developing anti-Ebola drug candidates.
Another drug maker coming to the fore was Crucell, a subsidiary of Johnson & Johnson. JNJ, -0.04% Crucell, like GlaxoSmithKline GSK, +0.34% , is developing a vaccine that would be injected into healthy individuals to prevent the disease from attacking. Others, like Chimerix and Tekmira, are working on treatments for those already afflicted with Ebola.
U.S. to review travel screening for Ebola, but no ban: White House WASHINGTON 2:00pm EDT - Mon Oct 6, 2014
WASHINGTON (Reuters) - The Obama administration is not considering a ban on travelers from countries most affected by the deadly Ebola virus outbreak but is reviewing possible additional passenger screening measures, the White House said on Monday.
"A travel ban is not something that we're currently considering," White House spokesman Josh Earnest told reporters at a daily briefing. "We feel good about the measures that are already in place."
But Earnest, speaking shortly before President Barack Obama was expected to receive an update on the outbreak centered in West Africa, added that the administration is not ruling out changes to screening procedures aimed at trying to identify potentially sick travelers.
"What we're looking to do is to review these screening measures," he said, adding that officials do not want to impede the transport systems critical to combating to deadly virus.
"We remain confident that we can keep those travel channels open and ensure the continued flow of supplies and personnel to the region, while at the same time putting in place screening measures ... on the ground in Africa, in transit, on the ground here in the United States that will ensure the safety of the traveling public and the American public," he said.
His comments come as an airline industry group said it will meet with health and safety officials on Monday to discuss the potential for additional screenings to identify travelers who may have been exposed to Ebola.
"The Spanish health minister has confirmed that a nurse who treated a victim of Ebola in Madrid has tested positive for the disease. The nurse is said to be the first person in the current outbreak known to have contracted Ebola outside Africa"
How could this have happened with all the precautions? This strain of Ebola must be more infectious than strains of past outbreaks."
"I just saw the alert on TV.
That nurse had treated a priest with ebola. And she got a little FEVER just a few days after the priest died. And the authorities let her go . She went on holidays!!! With fever!!!
Absolute nosense ...
By the way, my TV said that only 2 pharmas had the proper vaccine, one from Germany and the other one from US. I don't know if that is true. Any idea?"
"She is a health professional who took care of the infected with the disease who were repatriated and cared for at Carlos III" hospital, the director of Spain's public health department, Mercedes Vinuesa, told a news conference.
The nurse began to feel sick on 30 September. She is said to be in a stable condition.
She had treated elderly priest Manuel Garcia Viejo at the Madrid hospital when he was repatriated from Sierra Leone with the disease.
Fr Garcia Viejo died days later, the second Spanish priest to die after being repatriated from Africa with the disease.
The source said the nurse had tested positive for Ebola in initial tests and officials were awaiting final results."
'In 1976 I discovered Ebola - now I fear an unimaginable tragedy'
Peter Piot was a researcher at a lab in Antwerp when a pilot brought him a blood sample from a Belgian nun who had fallen mysteriously ill in Zaire
Rafaela von Bredow and Veronika Hackenbroch The Observer, Saturday 4 October 2014 17.00 EDT
Professor Peter Piot, the Director of the London School of Hygiene and Tropical Medicine: ‘Around June it became clear to me there was something different about this outbreak. I began to get really worried’ Photograph: Leon Neal/AFP Professor Piot, as a young scientist in Antwerp, you were part of the team that discovered the Ebola virus in 1976. How did it happen?
I still remember exactly. One day in September, a pilot from Sabena Airlines brought us a shiny blue Thermos and a letter from a doctor in Kinshasa in what was then Zaire. In the Thermos, he wrote, there was a blood sample from a Belgian nun who had recently fallen ill from a mysterious sickness in Yambuku, a remote village in the northern part of the country. He asked us to test the sample for yellow fever.
These days, Ebola may only be researched in high-security laboratories. How did you protect yourself back then?
We had no idea how dangerous the virus was. And there were no high-security labs in Belgium. We just wore our white lab coats and protective gloves. When we opened the Thermos, the ice inside had largely melted and one of the vials had broken. Blood and glass shards were floating in the ice water. We fished the other, intact, test tube out of the slop and began examining the blood for pathogens, using the methods that were standard at the time.
But the yellow fever virus apparently had nothing to do with the nun's illness.
No. And the tests for Lassa fever and typhoid were also negative. What, then, could it be? Our hopes were dependent on being able to isolate the virus from the sample. To do so, we injected it into mice and other lab animals. At first nothing happened for several days. We thought that perhaps the pathogen had been damaged from insufficient refrigeration in the Thermos. But then one animal after the next began to die. We began to realise that the sample contained something quite deadly.
But you continued?
Other samples from the nun, who had since died, arrived from Kinshasa. When we were just about able to begin examining the virus under an electron microscope, the World Health Organisation instructed us to send all of our samples to a high-security lab in England. But my boss at the time wanted to bring our work to conclusion no matter what. He grabbed a vial containing virus material to examine it, but his hand was shaking and he dropped it on a colleague's foot. The vial shattered. My only thought was: "Oh, shit!" We immediately disinfected everything, and luckily our colleague was wearing thick leather shoes. Nothing happened to any of us.
In the end, you were finally able to create an image of the virus using the electron microscope.
Yes, and our first thought was: "What the hell is that?" The virus that we had spent so much time searching for was very big, very long and worm-like. It had no similarities with yellow fever. Rather, it looked like the extremely dangerous Marburg virus which, like ebola, causes a haemorrhagic fever. In the 1960s the virus killed several laboratory workers in Marburg, Germany.
Were you afraid at that point?
I knew almost nothing about the Marburg virus at the time. When I tell my students about it today, they think I must come from the stone age. But I actually had to go the library and look it up in an atlas of virology. It was the American Centres for Disease Control which determined a short time later that it wasn't the Marburg virus, but a related, unknown virus. We had also learned in the meantime that hundreds of people had already succumbed to the virus in Yambuku and the area around it.
A few days later, you became one of the first scientists to fly to Zaire.
Yes. The nun who had died and her fellow sisters were all from Belgium. In Yambuku, which had been part of the Belgian Congo, they operated a small mission hospital. When the Belgian government decided to send someone, I volunteered immediately. I was 27 and felt a bit like my childhood hero, Tintin. And, I have to admit, I was intoxicated by the chance to track down something totally new.
just a few questions ? how important is the development of monoclonal antibiotics to the treatment of ebola? Does it have to target all 5 versions of the virus or just the EHF version?
thank you!
D...
Did you find what you were looking for? If so, please share it with us.
Nurse in Spain tests positive for Ebola in first infection outside west Africa
Nurse was part of team that treated priest who died in Madrid hospital last month after being flown home from Sierra Leone
Ashifa Kassam in Madrid The Guardian, Monday 6 October 2014 17.45 EDT
The Madrid hospital where a priest with Ebola was admitted last month. Photograph: Luca Piergiovanni/EPA
A nurse in Spain has tested positive for the Ebola virus after treating a patient repatriated to Madrid from Sierra Leone, the country’s health authorities said on Monday. The nurse is thought to be the first person to have contracted the virus outside west Africa.
The auxiliary nurse was part of the team attending to a Spanish missionary with Ebola who was repatriated two weeks ago. The 69-year-old missionary, Manuel García Viejo, died just four days after being brought to Madrid’s Carlos III hospital.
Health authorities said on Monday night that the nurse was in stable condition. She had alerted them to a slight fever on 30 September, said Antonio Alemany from the regional government of Madrid, and checked into a hospital in Alcorcón with a high fever on Sunday. Ebola protocol was immediately activated at the hospital and initial and secondary tests were both positive for the virus.
The patient, who is married with no children, was on holiday when she began showing symptoms, said Alemany.
Post by damnotagain on Oct 6, 2014 21:05:11 GMT -5
Inoculation of plants! Once infected tomatoe plants with the bacteria Agrobacterium. Based on research from a J. McLaughlin from Purdue , isolated the chemical asimicin from the bark of the paw paw tree. Injected it into the tomatoe plants . Inhibited the growth of the bacteria.
Short version , took 80 hours to get the extract.
I know they are using plants as a resource through inoculation , we can only hope someone shows up soon with the right combination.
Long ago and far away. Thanks for the information.
Democracy is the worst form of government except for all those others that have been tried. -Winston Churchill, House of Commons 11th of November, 1947.
“The scientific man does not aim at an immediate result. He does not expect that his advanced ideas will be readily taken up… His duty is to lay the foundation for those who are to come, and point the way.” – Nikola Tesla
I was just reading EBOLA articles regarding "burial crews" on strike for lack of payroll funds, etc! Thanks for the additional article that I will put at the head of my list.
Is it snowing -- yet -- in your area ! Been storming in mine. One would think it's Spring!
Inoculation of plants! Once infected tomatoe plants with the bacteria Agrobacterium. Based on research from a J. McLaughlin from Purdue , isolated the chemical asimicin from the bark of the paw paw tree. Injected it into the tomatoe plants . Inhibited the growth of the bacteria.
Short version , took 80 hours to get the extract.
I know they are using plants as a resource through inoculation , we can only hope someone shows up soon with the right combination.
Long ago and far away. Thanks for the information.
WASHINGTON — Ebola's economic toll could reach $32.6 billion by year's end if the disease ravaging Guinea, Liberia and Sierra Leone spreads across West Africa, the World Bank said Wednesday. The outbreak has the potential "to inflict massive economic costs" on those three countries and its closest neighbors, according to the bank's assessment.
"The international community must find ways to get past logistical roadblocks and bring in more doctors and trained medical staff, more hospital beds and more health and development support to help stop Ebola in its tracks," said Jim Yong Kim, the bank's president.
"Prudent" investment in better health systems could have lessened the economic fallout, he said.
The report estimated the costs of two scenarios: —more than $9 billion if the disease is rapidly contained in the three most severely affected countries.
—$32.6 billion if it takes a long time to contain Ebola there and the disease spreads to neighboring nations.
One way to ease the impact, the report said, was be if immediate action halted the outbreak and calmed fears. Concerns about the disease are causing neighboring countries to close their borders, and airlines and businesses to suspend commercial activities in the three worst-affected countries.
David Evans, a senior economist at the World Bank and co-author of the report, said fear prompts flights to be canceled, mining operations to halt, businesses to close and farming and investment to slow as people try to avoid putting themselves and their employees at risk. That behavior has a larger economic impact than sickness and death, he said.
"Policies to renew commercial activity while protecting other countries from contagion are what we need to mitigate this fear factor, which is key to mitigating the economic impact of the crisis," Evans told the Associated Press.
"Closing borders and halting flights has a huge impact," he said. "These economies trade with the outer world. They have international investment in mining. Liberia imports food. So as we close borders and cancel flights, there is a real impact on the food security and the incomes of the households in these countries." The World Health Organization estimates that Ebola has killed more than 3,400 people in West Africa and infected at least twice that many.
CHICAGO — The serious-faced physicians practice pulling on bulky white suits and helmets that make them look more like astronauts than doctors preparing to fight a deadly enemy. These training sessions at U.S. hospitals on Ebola alert and for health workers heading to Africa can make the reality sink in: Learning how to safely put on and take off the medical armor is crucial.
"When you're in the real deal, remember to take your time," biosafety expert John Bivona told doctors during a course this week at the University of Chicago's medical center. Suits splashed with patients' vomit or blood must be removed carefully, he explained.
"As much as possible, grab from the inside" to avoid touching contaminated parts of the suits, he said. "Be liberal with disinfectant."